No Detail Found!

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer

Author(s)
Seval Ay Department of Medical Oncology, Istanbul Medeniyet University, Goztepe Education and Research Hospital,Istanbul,Turkey
Deniz Tataroglu Ozyukseler Department of Medical Oncology, Kartal Lutfi Kirdar Education and Research Hospital,Istanbul,Turkey
Ozgecan Dulgar Department of Medical Oncology, Istanbul Medeniyet University, Goztepe Education and Research Hospital,Istanbul,Turkey
Mustafa Basak Department of Medical Oncology, Kartal Lutfi Kirdar Education and Research Hospital,Istanbul,Turkey
Mahmut Emre Yildirim Department of Medical Oncology, Kartal Lutfi Kirdar Education and Research Hospital,Istanbul,Turkey
Mahmut Gumus Department of Medical Oncology, Istanbul Medeniyet University, Goztepe Education and Research Hospital,Istanbul,Turkey
Abstract
Objective: To determine the relevance between the cut-o level of cancer antigen 125 (CA 125) level and long-term prognosis in high-grade serous ovarian cancer (HGSCs). Study Design: Observational study. Place and Duration of Study: Departments of Oncology, Medeniyet University Goztepe Education and Research Hospital, and Kartal Lut Kirdar Education and Research Hospital, Istanbul, Turkey, from January 2017 to June 2019. Methodology: Medical records of 230 women with HGSC were reviewed randomly from two Oncology Clinics. Descriptive analysis and CA 125 marker levels were evaluated with ve years of disease-free survival rate (DFS) and overall survival rate (OS). Patients were divided into groups of high and low initial CA 125 levels (cut-o e385U/ml). The ability of initial serum CA 125 levels in predicting the presence of marker-recurrence of ovarian cancer were analysed using ROC (Receiver operating characteristics) curve analysis. Results: Statistically signi cant predictive value of initial CA 125 level was calculated as 385U/ml (p=0.008). The 5-year DFS of high and low CA 125 levels for all stages in HGSC was statistically signi cant (p<0.001). The sub-group analysis demonstrated that the signi cant survival di erence was especially in FIGO stage III. Patients with HGSC <385 U/ml had a signi cantly improved 5-year DFS and OS rates within stage III disease: 5-year DFS (p = 0.008) and 5-year OS (p = 0.004) according to the strati cation of CA 125 level. Conclusion: Initial CA 125 level appeared to be of bene cial clinical predictive value for HGSC.
Publication Details
Page(s) 651-656
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 6, Year: 2021

Request the full text from PASTIC

Keywords
Overall survival, Disease-free survival, High-grade serous ovarian cancer, Tumor marker, Initial CA 125, Predictive value
0

Citations

0

Downloads

78

Views